Please find below the latest White Papers provided by agencies and companies within the healthcare and pharmaceutical industry. These are provided by external comoanies and are not approved of, checked or edited by PMLiVE or PMGroup Worldwide Ltd.
March 31, 2015 | White Papers and Resources |
Treatment initiation is a key focus for many pharma companies as part of their strategy to increase script writing and drive greater revenues.
Brought to you by Inizio
March 31, 2015 | White Papers and Resources |
One of the most consistent issues researchers face with segmentation is ensuring that it is actionable.
Brought to you by Inizio
March 31, 2015 | White Papers and Resources |
Exploring the opportunities for pharma in the ASEAN region and factors to consider when conducting healthcare market research.
Brought to you by Inizio
March 31, 2015 | White Papers and Resources |
Understanding the opportunities for biosimilars and the threats to innovator biologics
Brought to you by Inizio
March 31, 2015 | White Papers and Resources |
The Chinese healthcare market is experiencing a period of great change. Utilising local knowledge and detailed case studies, this webinar examines the likely impact on …
Brought to you by Inizio
March 27, 2015 | White Papers and Resources |
Utilising the benefits of mobile technology
Brought to you by Inizio
March 27, 2015 | White Papers and Resources |
Presenting a window on the world of your customer
Brought to you by Inizio
March 27, 2015 | White Papers and Resources |
Conducting research in one of the world’s largest pharma markets
Brought to you by Inizio
March 27, 2015 | White Papers and Resources |
The process of demand calibration of preference share (down-weighting) is often a proprietary “black box” technique, which can mean that the client is unsure how …
Brought to you by Inizio
March 27, 2015 | White Papers and Resources |
Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?
Brought to you by Inizio